Joseph C Schick Biolife Solutions Inc (BLFS) insider trading activity

Joseph C Schick is Director of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 43,953 shares of BLFS, which is worth approximately $968,284. The most recent transaction as insider was on Mar 08, 2024, when has been sold 11,264 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44K

0% 3M change

37.01% 12M change

Total Value Held $968,284

Joseph C Schick Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 08 2024	BUY Grant, award, or other acquisition	-	11,264 Added 20.4%	43,953 Common Stock
Nov 01 2023	BUY Grant, award, or other acquisition	-	608 Added 1.83%	32,689 Common Stock
Oct 01 2023	BUY Grant, award, or other acquisition	-	445 Added 1.37%	32,081 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	10,187 Added 24.36%	31,636 Common Stock
Nov 16 2022	SELL Open market or private sale	$71,550 $23.85 p/Share	3,000 Reduced 12.27%	21,449 Common Stock
Aug 01 2022	BUY Grant, award, or other acquisition	-	311 Added 1.26%	24,449 Common Stock
Jul 01 2022	BUY Grant, award, or other acquisition	-	409 Added 1.67%	24,138 Common Stock
Jun 01 2022	BUY Grant, award, or other acquisition	-	374 Added 1.55%	23,729 Common Stock
May 06 2022	BUY Grant, award, or other acquisition	-	14,730 Added 38.68%	23,355 Common Stock
Oct 07 2021	SELL Open market or private sale	$130,358 $40.11 p/Share	3,250 Reduced 27.37%	8,625 Common Stock
Aug 25 2021	SELL Open market or private sale	$98,513 $52.54 p/Share	1,875 Reduced 13.64%	11,875 Common Stock
Aug 18 2021	SELL Open market or private sale	$27,569 $44.11 p/Share	625 Reduced 4.35%	13,750 Common Stock
Jul 12 2021	BUY Grant, award, or other acquisition	-	5,000 Added 25.81%	14,375 Common Stock
May 24 2021	SELL Open market or private sale	$39,513 $31.61 p/Share	1,250 Reduced 11.76%	9,375 Common Stock
Nov 12 2020	SELL Open market or private sale	$207,000 $33.12 p/Share	6,250 Reduced 37.04%	10,625 Common Stock
Nov 12 2020	BUY Exercise of conversion of derivative security	$9,500 $1.9 p/Share	5,000 Added 22.86%	16,875 Common Stock
Oct 05 2020	BUY Grant, award, or other acquisition	-	5,000 Added 29.63%	11,875 Common Stock

JCS

Joseph C Schick

Director

Bothell, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLFS shares.

Notify only if

Value

Insider Trading

Get notified when an Biolife Solutions Inc insider buys or sells BLFS shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIOLIFE SOLUTIONS INC

Track Activities on BLFS

Account